How is Eli Lilly using telehealth for its European Foundayo obesity drug launch?

Eli Lilly plans to launch its oral obesity drug Foundayo in Europe primarily through telehealth channels. The strategy helps the company navigate most-favored-nations pricing constraints tied to its U.S. deal while testing early demand and avoiding immediate government reference pricing pressures.